AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOGEN INC. Director's Dealing 2022

Jan 21, 2022

30291_dirs_2022-01-21_d7c5c9ea-04f5-42ac-91e3-d5b9dd0f0731.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOGEN INC. (BIIB)
CIK: 0000875045
Period of Report: 2021-08-09

Reporting Person: ALEXANDER SUSAN H (EVP Chief Legal Off & Corp Sec)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-09	Common Stock	G	523	—	Disposed	41053	Direct
2022-01-19	Common Stock	A	2825	—	Acquired	43878	Direct

Footnotes

F1: Represents shares earned upon satisfaction of certain performance conditions associated with performance stock units granted on February 12, 2019. The shares will vest on February 12, 2022.